Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Jiang, Liyan ^a   Zhu, Wei ^b   Streicher, Katie ^b   Morehouse, Chris ^b   Brohawn, Philip ^b   Ge, Xiaoxiao ^a   Dong, Zhengwei ^c   Yin, Xiaolu ^c   Zhu, Guanshan ^c   Gu, Yi ^c   Ranade, Koustubh ^b   Higgs, Brandon W ^b   Yao, Yihong ^b   Huang, Jiaqi ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MEDIMMUNE   (United States)

^c ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; INSULIN RECEPTOR; INSULIN RECEPTOR A; INSULIN RECEPTOR B; ISOPROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; RNA ISOFORM;

ARTICLE; CANCER SURVIVAL; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MYELOID LEUKEMIA; OXIDATIVE PHOSPHORYLATION; PREVALENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; ALTERNATIVE RNA SPLICING; BIOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MORTALITY; NON SMALL CELL LUNG CANCER; NUCLEIC ACID DATABASE; OUTCOME ASSESSMENT; PATHOLOGY; PROCEDURES; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ALTERNATIVE SPLICING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RECEPTOR, INSULIN; RNA ISOFORMS; RNA, MESSENGER;

EID: 84898601043     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-131     Document Type: Article

References (23)

1. U.S. Cancer Statistics Working Group United States Cancer Statistics: 1999-2009 Incidence and Mortality Web-based Report 2013, Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute, Available at: http://www.cdc.gov/uscs, U.S. Cancer Statistics Working Group.
2. American Cancer Society Cancer Facts & Figures 2009, Atlanta, GA: American Cancer Society, American Cancer Society.
3. Ullrich A, Bell JR, Chen EY, Herrera R, Petruzzelli LM, Dull TJ, Gray A, Coussens L, Liao YC, Tsubokawa M, Mason, Seeburg PH, Grunfeld C, Rosen OM. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 1985, 313:756-761. 10.1038/313756a0, 2983222.
4. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri1 R. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999, 19:3278-3288. 84122, 10207053.
5. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 2009, 30(6):586-623. 10.1210/er.2008-0047, 19752219.
6. Shaw LM. The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer. Cell Cycle 2011, 10:1750-6. 10.4161/cc.10.11.15824, 3142458, 21597332.
7. Vella V, Pandini G, Sciacca L, Mineo R, Vigneri R, Pezzino V, Belfiore A. A novel autocrine loop involving IGF-II and the insulin receptor isoform-A stimulates growth of thyroid cancer. J Clin Endocrinol Metab 2002, 87:245-254. 10.1210/jcem.87.1.8142, 11788654.
8. Belfiore A, Malaguarnera R. Insulin receptor and cancer. Endocr Relat Cancer 2011, 18:R125-47. 10.1530/ERC-11-0074, 21606157.
9. Kim JS, Kim ES, Liu D, Lee JJ, Solis L, Behrens C, Lippman SM, Hong WK, Ignacio I, Wistuba I, Lee H. Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer. Cancer 2012, 118(9):2454-65. 10.1002/cncr.26492, 3298843, 21952750.
10. Huang J, Morehouse C, Streicher K, Higgs BW, Gao J, Czapiga M, Boutrin A, Zhu W, Brohawn P, Chang Y, Viner J, LaVallee T, Richman L, Jallal B, Yao Y. Altered expression of insulin receptor isoforms in breast cancer. PLoS One 2011, 6(10):e26177. 10.1371/journal.pone.0026177, 3202518, 22046260.
11. Wilkerson MD, Yin X, Hoadley KA, Liu Y, Hayward MC, Cabanski CR, Muldrew K, Miller CR, Randell SH, Socinski MA, Parsons AM, Funkhouser WK, Lee CB, Roberts PJ, Thorne L, Bernard PS, Perou CM, Hayes DN. Lung squamous cell carcinoma mRNA expression subtypes are reproducible, clinically important, and correspond to normal cell types. Clin Cancer Res 2010, 16(19):4864-75. 10.1158/1078-0432.CCR-10-0199, 2953768, 20643781.
12. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, Cuttitta F. Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 1996, 271(19):11477-83. 10.1074/jbc.271.19.11477, 8626706.
13. Yee D. Insulin-like growth factor receptor inhibitors: baby or the bathwater?. J natl cancer inst 2012, 104(13):975-81. 10.1093/jnci/djs258, 3634550, 22761272.
14. Ramalingam SS, Spigel DR, Chen D, Steins MB, Engelman JA, Schneider CP, Novello S, Eberhardt WE, Crino L, Habben K, Liu L, Jänne PA, Brownstein CM. Randomized phase II study of Erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer. J Clin Oncol 2011, 29(34):4574-4580. 10.1200/JCO.2011.36.6799, 22025157.
15. Garofalo C, Manara MC, Nicoletti G, Marino MT, Lollini PL, Astolfi A, Pandini G, López-Guerrero JA, Schaefer KL, Belfiore A, Picci P, Scotlandi K. Efficacy of and resistance to anti-IGF-1R therapies in Ewing's sarcoma is dependent on insulin receptor signaling. Oncogene 2011, 30:2730-2740. 10.1038/onc.2010.640, 21278796.
16. Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134(5):703-7. 10.1016/j.cell.2008.08.021, 18775299.
17. Warburg O. On the origin of cancer cells. Science 1956, 123(3191):309-14. 10.1126/science.123.3191.309, 13298683.
18. Levine AJ, Puzio-Kuter AM. Tumor suppressor genes the control of the metabolic switch in cancers by oncogenes. Science 2010, 330:1340-4. 10.1126/science.1193494, 21127244.
19. Pollak M. Insulin and insulin-like growth factor signaling in neoplasia. Nat Rev Cancer 2008, 8:915-928. 10.1038/nrc2536, 19029956.
20. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-5. 10.1016/j.ceb.2005.08.001, 16098727.
21. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009, 119:1420-8. 10.1172/JCI39104, 2689101, 19487818.
22. Aoudjit F, Vuori K. Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract 2012, 2012:283181. 3332161, 22567280.
23. Anastassiou D, Rumjantseva V, Cheng W, Huang J, Canoll PD, Yamashiro DJ, Kandel JJ. Human cancer cells express Slug-based epithelial-mesenchymal transition gene expression signature obtained in vivo. BMC Cancer 2011, 11:529. 10.1186/1471-2407-11-529, 3268117, 22208948.